Achieve Life Sciences(DE:SP4P)
€5.35-0.15 (-2.73%)
DE:SP4P
Achieve Life Sciences ownership
€5.35
At close:-0.15 (-2.73%)
Achieve Life Sciences (SP4P) Ownership - Who Owns Achieve Life Sciences?
3 Followers
Achieve Life Sciences (SP4P) Ownership Overview
- 0.22% Insiders
- 10.09% Mutual Funds
- 59.39% Other Institutional Investors
- 10.71% ETFs
- 19.59% Public Companies and Individual Investors
The ownership structure of Achieve Life Sciences (DE:SP4P) stock is a mix of institutional, retail, and individual investors. Approximately 80.18% of the company’s stock is owned by Institutional Investors, 0.22% is owned by Insiders, and 19.59% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Achieve Life Sciences (DE:SP4P) stock is a mix of institutional, retail, and individual investors. Approximately 80.18% of the company’s stock is owned by Institutional Investors, 0.22% is owned by Insiders, and 19.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €212,333 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 5,487,278 | Institution | 5.33% | 32,188,373 |
| Vanguard Index Funds | 4,065,758 | Institution | 3.95% | 23,849,736 |
| Vanguard | 3,719,463 | Institution | 3.61% | 21,818,370 |
| Ishares | 3,193,599 | Institution | 3.10% | 18,733,652 |
| Spdr | 2,368,748 | Institution | 2.30% | 13,895,076 |
| Mutual Fund Series Trust | 2,220,000 | Institution | 2.16% | 13,022,520 |
| Franklin Strategic Series | 1,095,791 | Institution | 1.06% | 6,427,910 |
| Fidelity Salem Street Trust | 937,252 | Institution | 0.91% | 5,497,920 |
| Simplify | 932,105 | Institution | 0.91% | 5,467,728 |
| Fidelity Concord Street Trust | 870,952 | Institution | 0.85% | 5,109,004 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,065,758 | Institution | 3.95% | 23,849,736 |
| Mutual Fund Series Trust | 2,220,000 | Institution | 2.16% | 13,022,520 |
| Franklin Strategic Series | 1,095,791 | Institution | 1.06% | 6,427,910 |
| Fidelity Salem Street Trust | 937,252 | Institution | 0.91% | 5,497,920 |
| Fidelity Concord Street Trust | 870,952 | Institution | 0.85% | 5,109,004 |
| Vanguard Scottsdale Funds | 537,429 | Institution | 0.52% | 3,152,559 |
| Schwab Capital Trust | 232,138 | Institution | 0.23% | 1,361,722 |
| Tiaa-cref Funds | 170,650 | Institution | 0.17% | 1,001,033 |
| Vanguard Institutional Index Funds | 42,235 | Institution | 0.04% | 247,751 |
| Vanguard Valley Forge Funds | 33,105 | Institution | 0.03% | 194,194 |
FAQ
Who Owns Achieve Life Sciences (DE:SP4P)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 80.18% of the company's stock is held by institutional investors, 0.22% is held by insiders, and 19.59% is held by public companies and individual investors.
What percentage of Achieve Life Sciences (DE:SP4P) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 80.18% of Achieve Life Sciences (DE:SP4P) stock is held by institutional investors: 10.09% by mutual funds, 10.71% by ETFs and 59.39% by other institutional investors.
What percentage of Achieve Life Sciences (DE:SP4P) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 19.59% of Achieve Life Sciences (DE:SP4P) stock is held by public companies and individual investors.
Who owns the most shares of Achieve Life Sciences (DE:SP4P)?
BlackRock, Inc. owns the most shares of Achieve Life Sciences (DE:SP4P).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

